Table 2 Docking based molecular interaction of Top 3 drugs-protein with respect to its standard.

From: Repurposing FDA approved drugs for psoriasis indications through integrated molecular docking, one-SVM algorithm, and molecular dynamics simulation approaches

Drug-target complex

Target site score

XPG score

MMGBSA

Hydrogen bond

Hydrophobic bond

Salt bridge

Pi-Pi stacking

Pi cation

Pioglitazone-Amine oxidase [flavin- containing] A (2BXR)

1.076

− 12.745

− 86.364

Ser209 (1) Ala68 (1) Tyr69 (2) Met445 (1)

Ala68, Tyr69, Tyr444, Ile207, Phe208, Leu97, Ile325, Cys323, Leu337, Ile335

Glu206

 

Phe208

Tofacitinib- Amine oxidase [flavin- containing] A (2BXR)

 

− 9.689

− 39.433

Tyr69 (2) Ala68 (1) Ala209 (1)

Tyr69, Ala68, Ile180, Ile207, Phe208, Leu337, Phe352, Ile335, Tyr407, Tyr444, Met445

–

–

–

Trimipramine- Muscarinic acetylcholine receptor M1 (6WJC)

1.135

− 13.507

− 65.37

–

Tyr106, Ile74, Trp157, Val113, Phe197, Ala196, Ala193, Val385, Leu183, Tyr381, Trp378, Tyr404, Cys407, Tyr408

Asp105

Tyr381

Trp381Trp378Tyr404

Dimetindene- Muscarinic acetylcholine receptor M1 (6WJC)

 

− 12.017

− 74.224

–

Tyr106, Trp157, Phe197, Ala196, Leu183, Ala193, Tyr381, Trp378, Tyr408, Cys407, Tyr404, Trp378, Tyr381

–

Tyr106 Trp157

Trp378Tyr381

Anthralin- Muscarinic acetylcholine receptor M1 (6WJC)

 

− 9.465

− 36.031

–

Tyr106, Trp157, Ala193, Ala196, Phe197, Tyr381, Trp378, Tyr404, Cys407, Tyr408

–

–

–